Sharp Brains: Brain Fitness and Cognitive Health News

Meet these world-class experts and innovators

Confirmed Summit Speakers

Dr. Andrea Serino, Head of Neuroscience at MindMaze

Andrea Serino is currently Head of Neuroscience at MindMaze and Invited Professor at the Center for Neuroprosthetics of the EPFL, and he will be SNSF Professor at the University Hospital of Lausanne from 2017. He got his PhD in Neuropsychology at the University of Bologna, where he was also assistant professor from 2006 to 2012. His main research topic is understanding the neurocognitive basis of body and self experience in space. To this aim he has used multiple experimental techniques, both in healthy volunteers and in brain damaged or neuropsychiatric patients, including psychophysics, non-invasive brain stimulation, fMRI, EEG and neural network modelling. He received in 2006 the De Renzi Prize from the Italian society of Neuropsychology and in 2016 the Leenards Prize for translational research.

Alexandra Morehouse

Alexandra Morehouse, CMO of Banner Health

Alexandra M. Morehouse is Senior Vice President & Chief Marketing Officer for Banner Health, one of the nation’s largest nonprofit health systems. Prior to Banner Health, she was the Vice President of Brand Management at Kaiser Permanente. Previously, Ms. Morehouse was CMO of AAA, where she oversaw all strategy, advertising, branding, media relations, and customer relationship management. Ms. Morehouse has also served as co-chair of the Harvard Business School Global Technology Conference and on the boards of the Harvard Business School Community Partners, SnapFish, Yerba Buena Center for the Arts, ODC Dance, and UC Davis. She graduated with high honors from Harvard University and has an M.B.A. from Harvard Business School.

Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)

Prior to NIO, Alison was Manager of Industry Relations at the Ontario Brain Institute (OBI) in Canada, where she developed and launched several innovative funding programs for seed stage and product development investments. Prior to the OBI Alison worked in Equity Research at Bloom Burton & Co, a boutique life science investment bank in Toronto, Canada. She also served on the board of AGE Inc. a social venture developing educational tools for frontline healthcare staff. Alison has a PhD in Neuroscience and an MBA from McMaster University, a Masters in Neurokinetics from the University of Quebec at Montreal, and a Bachelor of Kinesiology (honors) from Brock University.

Alvaro Fernandez

Alvaro Fernandez, CEO and Editor-in-Chief of SharpBrains

Alvaro Fernandez, named a Young Global Leader by the World Economic Forum, runs SharpBrains, an independent market research firm tracking health and performance applications of brain science. He has been quoted by The New York Times, The Wall Street Journal, and CNN, among others. Mr. Fernandez is the co-author of “The SharpBrains Guide to Brain Fitness: How to Optimize Brain Health and Performance at Any Age” (translated into Spanish, Polish and Japanese), and the Editor-in-chief of SharpBrains’ recent market report on Pervasive Neurotechnology and IP. Alvaro has an MBA and MA in Education from Stanford University, and a BA in Economics from Universidad de Deusto in his native Spain.

Robert Bilder

Dr. Bob Bilder, Direc­tor of the UCLA Ten­nen­baum Cen­ter for the Biol­ogy of Cre­ativ­ity

Dr. Bob Bilder is the Direc­tor of the Ten­nen­baum Cen­ter for the Biol­ogy of Cre­ativ­ity in the Jane & Terry Semel Insti­tute for Neu­ro­science and Human Behav­ior, and the Michael E. Ten­nen­baum Fam­ily Pro­fes­sor of Psy­chi­a­try & Biobe­hav­ioral Sci­ences and Chief of Med­ical Psy­chol­ogy — Neu­ropsy­chol­ogy at David Gef­fen School of Med­i­cine. He has received many awards for his research con­tri­bu­tions, served on diverse fed­eral and inter­na­tional advi­sory boards, pro­vided edi­to­r­ial ser­vice to many schol­arly jour­nals, and received mul­ti­ple grants from the NIH, pri­vate foun­da­tions, and industry. Learn more.

Dr. Brian Iacoviello, Director of Scientific Affairs at Click Therapeutics

Brian combines clinical and scientific initiatives at Click Therapeutics with his role as Assistant Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. Prior to joining Click Therapeutics, he was the Director of Psychotherapy Research in the Mood and Anxiety Disorders Program at Mount Sinai, conducting over $1M in NIH and foundation-funded research investigating neurobehavioral interventions for mood and anxiety disorders. He holds a Ph.D. and M.A., Clinical Psychology, from Temple University; and a B.A. with Honors in Psychology and Entrepreneurship from Johns Hopkins University.

Charlie Hartwell

Charlie Hartwell, Operating Partner at the Bridge Builders Collaborative

Charlie helps fund and support the visions of social entrepreneurs who have scalable business models for applications, practices, products and tools that build bridges for mind-training. He is a Harvard Business School graduate who has led, founded, run and worked in organizations in 16 different industries. Previously Charlie was President of Ideas to Go, an innovation-consulting firm. His career has included Wall Street, corporate marketing stints at HJ Heinz and Pillsbury. In 1998, he formed yourexpedition, the first for-profit expedition company in U.S. history, launched by the historic Bancroft Arnesen Expedition across Antarctica by polar explorers Ann Bancroft and Liv Arnesen.

Dr. Corey McCann, CEO of Pear Therapeutics

Corey has background as a physician, scientist, entrepreneur, and healthcare investor. Prior to founding Pear, he was an investor with MPM Capital and with RiverVest Venture Partners. Previously he was with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies and led McKinsey’s Central Nervous System (CNS) expertise group, serving clients across pharma and biotech. He is a founding member of multiple start-ups including Alcyone Lifesciences. Dr. McCann’s post-graduate training was at Harvard University, Washington University in St Louis, and at the Massachusetts General Hospital, and he graduated summa cum laude from The Pennsylvania State University where he was an Evan Pugh Scholar.

Dr. Daniel Perez-Marcos, Senior Scientist at MindMaze

Dr. Daniel Perez-Marcos received the Dr.-Ing. degree in Biomedical Engineering in 2007 (TU Ilmenau, Germany), for the development of neurofeedback applications for the treatment of cognitive impairments in epilepsy. Daniel joined MindMaze in 2012. His mission is to ensure scientific, clinical and technological excellence of the company’s virtual reality healthcare solutions for neurorehabilitation. Prior to joining MindMaze, Daniel was a scientific researcher at IDIBAPS and the Experimental Virtual Environments Lab for Neuroscience and Technology in Barcelona from 2006 to 2012, where he worked on the integration of immersive virtual reality, body ownership, brain-computer interfaces and haptics to enhance telepresence experiences for psychology and neuroscience applications.

Debra Gilmore, Exec­u­tive Director of The Arrow­smith Pro­gram

Debbie Gilmore is the new Executive Director of Arrowsmith Program, having been Arrowsmith’s representative in Australia and New Zealand for 18 months. Debbie first heard about the Arrowsmith Program when she was Head of Diverse Learning Needs at the Catholic Education Office, Sydney, Australia. Her work as a teacher, literacy adviser, assistant principal and principal helped her understand the need to ‘unlock’ the potential of students with learning difficulties, and her role as a mother of a son with such challenges gave her first hand experience of their struggles. Debbie holds a Masters of Education and various Graduate Certificates in Education.

Dr. Eddie Martucci, CEO of Akili Interactive Labs

Dr. Martucci is co-founder and CEO at Akili Interactive Labs, a digital health company aiming to make the first regulatory-approved diagnostic and therapeutic video games. He spearheaded the clinical partnerships that Akili now has with Pfizer and multiple top-tier academic institutions. Dr. Martucci is also a Principal at PureTech Ventures. He was previously a Kauffman Entrepreneur Fellow. Dr. Martucci completed his graduate work at Yale University in the Departments of Pharmacology and Molecular Biophysics & Biochemistry, and received a BS in Biochemistry from Providence College and a PhD and MPhil from Yale University.

Edward Kliphuis, Investment Director of Merck Ventures

Edward Kliphuis, Investment Director at Merck Ventures and Board Observer at Akili Interactive Labs, looks for new investment opportunities for the 300 million euro Merck Ventures fund. Previously he was at Kempen & Co, a pan European merchant bank headquartered in Amsterdam, the Netherlands, where he worked in the Life Sciences Securities team. Edward was instrumental in the team’s continuous fundraising efforts for listed European small and mid-cap biotech companies in over 20 deals. He holds an M.Sc. degree in Biopharmaceutical Sciences from Leiden University, the Netherlands, with specializations in pharmacology and science based business.

Elizabeth Zelinski

Dr. Elizabeth Zelinski, Director of the Digital Aging Center at USC Davis School of Gerontology

Dr. Elizabeth Zelinski studies mechanisms of longitudinal changes in memory, intelligence, and language in healthy adults aged 30 – 97. She believes that some of the negative change associated with aging can be reduced by engagement in challenging activities such as cognitive training games. She served as a principal investigator of the IMPACT study, a large clinical trial of a program that uses principles of brain plasticity. She recently found that modest improvements to healthy older adults’ cognition with direct training were equivalent to the improvements seen with aerobic exercise interventions. Zelinski has been president of the American Psychological Association Division of Adult Development and Aging, is the the Rita and Edward Polusky Chair in Education and Aging and professor of gerontology and psychology in the Davis School of Gerontology at the University of Southern California and is the inaugural Director of its Digital Aging Center.

Dr. Gahan Pandina, Senior Director & Venture Leader at Janssen Research & Development

Working at Janssen Research and Development, Pharmaceutical Companies of Johnson & Johnson, Dr. Pandina’s team is developing a system of tools and technologies to optimize novel medication development for Autism Spectrum Disorder (ASD). Over the past 14 years at Janssen, Dr. Pandina has served as the clinical leader for several global, Phase 2a/2b drug development programs in the areas of schizophrenia & cognition, ADHD, mood, and sleep disorders. He is a licensed clinical psychologist, and serves on the board of two non-profit organizations focused on mental health. He received a BA in Psychology from the University of Vermont, and a PhD in Clinical Psychology from Binghamton University in Binghamton, NY, and completed doctoral fellowships in both Neuropsychology and Child and Adolescent Neuropsychology at the Robert Wood Johnson Medical School.

Dr. Judson Brewer, Founder & Research Lead of Claritas Mindsciences

Dr. Judson Brewer MD, PhD, the founder of Claritas MindSciences and creator of Eat Right Now and Craving to Quit, is a thought leader in habit change and the “science of self-mastery,” with 20 years of experience in mindfulness training. He has taught at Yale University, published numerous peer-reviewed articles and book chapters, spoken at international conferences, and his work has been featured at TEDMED, TEDx, Time magazine, Forbes, BBC, NPR, and others. Currently, on top of founding Claritas, Jud is also an Associate Professor of Psychiatry and Medicine at University of Massachusetts School of Medicine, where he is Director of Research at the Center for Mindfulness.


Dr. Kenneth Kosik, Co-Director of the UC Santa Barbara Neuroscience Research Institute

Dr. Kosik received his M.D. degree from the Medical College of Pennsylvania, completed a neurology residency from Tufts New England Medical Center, and held various appointments at the Harvard Medical School. In the fall of 2004 he assumed the co-directorship of the Neuroscience Research Institute and the Harriman Chair at the University of California Santa Barbara. He has received multiple awards, including a Whitaker Health Sciences Award from MIT, the Derek Denny-Brown Neurological Scholar Award from the ANA, the Zenith Award from the Alzheimer’s Association, and a NASA Group Achievement Award.

Linda Raines, CEO of the Mental Health Association of Maryland

Linda Raines has been working at the Mental Health Association of Maryland in several capacities for 30 years. For 100 years, the Mental Health Association of Maryland has addressed the mental health needs of Marylanders of all ages through programs that educate the public to increase understanding and provide resources, advance public policy to improve care and outcomes, and monitor the quality of services received by individuals living with mental illness and substance use disorders. Previously, Linda was a Political Organizer & Legislative Associate at Common Cause.

Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)

Dr. Grabb oversees the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs at the NIMH, with a $40M annual budget that supports a diverse technology portfolio ranging from the latest advancements in areas such as optogenetics and large scale electrophysiological recording, to drug and device development, high throughput screening tools, biomarkers and mobile health technologies. The goals and objectives for these programs aim to: 1) identify and promote specific commercializable technology development that could benefit NIMH stakeholders and 2) identify bottlenecks in the commercialization of biomedical technologies and provide solutions to the issues. Dr. Grabb developed the first SBIR Phase II competing renewal solicitation that supports technology development into the “the valley of death”. She has also played an active part in the NIH SBIR Technical Assistance Programs that provide SBIR grantees with commercialization assistance. Additionally, she manages a non-SBIR program that supports the development and testing of novel therapeutics for pediatric mental disorders. Dr. Grabb has received several NIMH Director’s Awards for achievements in program development, leadership and management.

Margaret Moore, Co-Founder of the Institute of Coaching at McLean Hospital

Margaret Moore (aka Coach Meg) is co-founder and co-director of the Institute of Coaching at McLean Hospital, an affiliate of Harvard Medical School. She is a 17-year veteran of the biotechnology industry, where she served in multiple executive roles until 2000, when she shifted from high tech medicine to coaching in healthcare and wellness, and founded Wellcoaches Corporation – strategic partner of the American College of Sports Medicine. She is a co-founder and executive board member of the National Consortium for Credentialing Health & Wellness Coaches and led the formation of a strategic partnership with the National Board of Medical Examiners to deliver national standards and certification of health and wellness coaches.

Mark Watson, Co-Director of the Watson Centre for Brain Health

As an educator and athlete, Mark has always appreciated the role of rehabilitation in increasing performance. As the co-Director of the Watson Centre for Brain Health, Mark’s mission is to improve the lives of people that have suffered a brain injury and/or concussion by implementing brain changing programs to increase brain capacities and cognitive functioning. He’s also the CEO of Eaton Educational Group, which runs several schools to help students with learning disabilities. Mark holds a Bachelor’s degree in Physical Education and Recreation from the University of Alberta, and a Master’s degree in Educational Leadership.

Michael Meagher, Pres­i­dent of Cogniciti

Michael Meagher runs Cogniciti, the cognitive health spin-off from research center and hospital Baycrest up in Ontario, Canada. His experience has been a mix of serial entrepreneur and corporate executive. His career began with a 9-year stint in Procter & Gamble, and continued by running 5 successful business services firms where he helped create more than 3,000 net new jobs. Michael has been a lecturer at the Ivey School of Business, co-authored a book on environmental marketing, managed a successful federal election campaign, chaired and served on numerous Boards, and received multiple awards from the Young Presidents Organization.

Dr. Michael Merzenich, Emeritus Professor at UCSF and Winner of the 2016 Kavli Prize in Neuroscience

For more than three decades, Dr. Merzenich has been a leading pioneer in brain plasticity research. In the late 1980s, Dr. Merzenich was on the team that invented the cochlear implant, now distributed by Advanced Bionics. In 1996, Dr. Merzenich was the founding CEO of Scientific Learning Corporation (Nasdaq: SCIL), and in 2004 became co-founder and Chief Scientific Officer of Posit Science. Dr. Merzenich earned his BS degree at the University of Portland and his PhD at Johns Hopkins. He retired from his long career as Francis A. Sooy Professor and Co-Director of the Keck Center for Integrative Neuroscience at the University of California at San Francisco in 2007. He was elected to the National Academy of Sciences, the Institute of Medicine, and recently won the 2016 Kavli Prize in Neuroscience

Dr. Neal Cohen, clinical psychologist at The Synapse System

Dr. Cohen is a Georgia licensed psychologist with over 20 years of experience in the assessment and treatment of substance use disorders. He received a Master’s degree in Clinical Psychology from the Georgia School of Professional Psychology and his Doctorate from Argosy University. Dr. Cohen has a particular interest in substance abuse and cognitive disorders. Presently, he is conducting research on how adolescent substance abuse programming can be modified to accommodate the deficits in executive function commonly found in this population.

Nikhil Sri­ra­man, IP Analyst at SharpBrains

Nikhil Sri­ra­man is a patent attor­ney admit­ted to prac­tice before the United States Patent and Trade­mark Office (USPTO). Nikhil has held posi­tions at the USPTO, IP law firms and in-house at For­tune 500 com­pa­nies. He cur­rently serves as Primal’s Vice Pres­i­dent of Intel­lec­tual Prop­erty, as well as Sharp­Brains’ Intel­lec­tual Prop­erty Analyst. With degrees by DePaul University College of Law and University of Michigan, Nikhil’s professional experience includes legal and engineering work at Ford and Johnson Controls.

Dr. Peter White­house, Pro­fes­sor of Neu­rol­ogy at Case West­ern Reserve University

Peter J. White­house, MD, PhD is Pro­fes­sor of Neu­rol­ogy as well as for­mer Pro­fes­sor of Cog­ni­tive Sci­ence, Psy­chi­a­try, Neu­ro­science, Psy­chol­ogy, Nurs­ing, Orga­ni­za­tional Behav­ior, Bioethics and His­tory. With col­leagues he dis­cov­ered fun­da­men­tal aspects of the cholin­er­gic pathol­ogy in Alzheimer’s and related demen­tias. He is clin­i­cally active at Uni­ver­sity Hos­pi­tals of Cleve­land in the Joseph Foley Elder Health Cen­ter at Fairhill Cen­ter, and his research inter­ests include the devel­op­ment of more effec­tive treat­ments for indi­vid­u­als with cog­ni­tive impair­ment, includ­ing drugs and non-biological inter­ven­tions, eth­i­cal issues in the med­ical pro­fes­sion and inte­gra­tive health care sys­tems


Richard Varn, Presidential Appointee at the Center for Advanced Technology and Neuroscience at Educational Testing Services (ETS)

Richard is focused on role of predictive analytics to help education gain proof of outcome and proof of value, and to gain efficiency in educational settings. In addition to work in building a Center for Advanced Technology and Neuroscience, he serves on the Work Force Readiness business development team and oversees Enterprise Resiliency Management. Previously, Richard was the Chief Information Officer for the City of San Antonio and the State of Iowa, among other responsibilities.

Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad

Dr. Jakobovits is President at Experiad Solutions, a startup that is developing new software for behavioral therapy and other clinical applications. He is a Research Affiliate with the University of Washington Autism Center and an Affiliate Professor of Radiology. His prior venture, Vivalog Technologies, was sold to McKesson in 2008. He served as Vice President at McKesson for 5 years before leaving to launch Experiad in 2013. Dr. Jakobovits received his PhD in Computer Science from the University of Washington in 1999. He is widely published in computer science and informatics journals, and has been awarded several patents. He has raised over $5M in seed capital for his startups through NIH Small Business Innovative Research grants.

Rita Carter, science writer, broadcaster and BBC contributor

Rita Carter is a writer, broadcaster and lecturer who specialises in brain science. She is the author of “Mapping the Mind” the first comprehensive layman’s guide to neuropsychology. Other titles include “Exploring Consciousness” , “Multiplicity – the New Science of Personality” and “The Brain Book”. Rita was a TV presenter and produced and presented radio and programmes about medicine and psychology. She writes for a wide range of newspapers and magazines, including BBC Focus, New Scientist, and the Daily Mail, and talks and lectures about brain science throughout the world.

Ron Oberleitner, CEO of Behavior Imaging Solutions

Ron is a widely recognized thought leader in the health IT and autism communities, having successfully brought numerous innovations to market, including TalkAutism and AutismCares. He is a leading expert and widely published researcher on the use of health informatics and telemedicine for special needs, all of this work in recent years stemming from a successful career with market-leading medical device companies. He is a widely published expert on the use of health informatics and telemedicine for special needs, and has more than 20 years of executive-level management experience leading product development in large medical device companies. He has proven track record of bringing helpful technologies to market for improved clinical operations and treatment of various medical conditions, autism and other developmental disabilities.

Ron Riesenbach, Managing Director of the Canadian Centre for Aging and Brain Health Innovation (CC-ABHI)

On top of his role at CC-ABHI, Ron is the VP Innovation and Chief Technology Officer of Baycrest Health Sciences, where he leads a diverse team of professionals developing novel solutions to support clinical care, research and education into ageing and brain health. Prior to joining Baycrest, he was the VP of Emerging Business with the Ontario Telemedicine Network, and led the team that built OTN’s state-of-the-art technology infrastructure, applications and service delivery model. Ron is a Professional Engineer, holds an MSc in Electrical Engineering from the Technion Israel Institute of Technology and an MBA from the Rotman School of Management at the University of Toronto.

Ruth Poliakine Baruchi, CEO of MyndYou

Ruth is the CEO and Founder of MyndYou, an innovative start-up developing a data-driven platform for the 43 million people living with Alzheimer’s worldwide and their family members so that they can more easily and better manage care. She brings over 15 years of experience in leadership and management of innovative business & technology projects including General Management of Medical Device startup, while working with customers, business partners and suppliers worldwide.

Sandra Bond Chapman

Dr. Sandra Bond Chapman, Founder and Director, Center for BrainHealth at The University of Texas at Dallas.

Sandra Bond Chapman, Ph.D. is founder and chief director of the Center for BrainHealth, professor of behavioral and brain sciences, Dee Wyly Distinguished University Chair at The University of Texas at Dallas and author of Maker Your Brain Smarter. As a cognitive neuroscientist with more than 40 funded research grants and more than 200 publications to her credit, Dr. Chapman is committed to unlocking human brain potential across the lifespan. Her scientific study elucidates and applies novel methodologies to advance creative and critical thinking, strengthen healthy brain development, protect against brain decline, restore the brain after injury and incite innovation throughout life.

Sanjiv Rai, founder of

Sanjiv Rai is a first-generation Indian innovator and serial entrepreneur. He is the Founder, Chairperson and Chief Solver of multiple startups under Billion Innovators and Chairperson at ARE Technologies and his venture initiatives AceWP Innovation Labs and BillionInnovators intend to promote innovation in India and abroad. As a serial Entrepreneur or Innovator he has worked on AI based convergence and design algorithms, on a variety of products and solutions such as network convergence enabling D5 chip, AceWP, PlasmaPHI, innovate2learn, agniie devices, ChazeMe, SmartSAPS(Smart Secured Automated Payment Solutions), coolATM and Rosenbridges Future Cities/Smart Buildings and CHANDRA project for NASA towards permanent human inhabitancy on outer planets.

Dr. Sarah Banks, Head of Neuropsychology at the Cleveland Clinic Lou Ruvo Center for Brain Health

Sarah J. Banks, PhD, is the head of the neuropsychology program at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada. She is also Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Her clinical practice involves characterizing patients’ cognitive profile, and integrating this information with medical and psychological factors to help with diagnosis and in suggesting appropriate interventions. Dr. Banks is also actively involved in training, supervising clinical psychology practicum students from Univeristy of Nevada Las Vegas. She has particular interest in neuroimaging, and uses structural and functional MRI to investigate cognition and emotion.

Scott Pawson, Sr. Product Manager, New Product Lead at Pearson Clinical Assessment

Scott is a Sr. Product Manager and New Product Lead with Pearson’s Clinical Assessment group. He leads the Cognitive Intervention portfolio which includes the Cogmed and RehaCom platforms. Previously, Scott was the General Manager of the Pearson Clinical Assessment business in Canada. Scott obtained his MA in Psychology from Wilfrid Laurier University in Waterloo, Ontario. He resides and works in Burlington, Ontario, Canada with his wife & two sons.

Susan Hoffman, Director of the Osher Lifelong Learning Institute at UC-Berkeley

Susan initiated the Osher Lifelong Learning Institute at SFSU in 2002 and moved to UC Berkeley in 2007 to re-envision and build an entirely new Osher program. Before joining UC-Berkeley, Susan worked for the California State University creating new interdisciplinary and international programs. Previously, Hoffman served for a decade as the executive director of the California Confederation of the Arts, advocating for California artists, art educators, and arts organizations in Sacramento and Washington D.C., and developing cultural and educational policies. Her faculty appointments have been in creative writing, theatre, and political philosophy.

Tan Le, CEO of Emotiv

Tan Le is a technology entrepreneur, business executive and sought-after speaker. She is founder and CEO of Emotiv Lifesciences, a bioinformatics company that advances understanding of the human brain and identifies biomarkers for mental and other neurological conditions using electroencephalography (EEG). She is pursuing the dream of performing inexpensive and widespread brain function screening to catch early signs of autism, epilepsy, learning disabilities, ADHD, and other conditions. Tan has received many awards and appeared in innumerable ‘Who’s Who in Australia’ lists; she was named among Fast Company’s Most Influential Women in Technology in 2010 and Forbes‘ 50 Names You Need to Know in 2011. In 2009, she was honored by the World Economic Forum as a Young Global Leader since 2009, and in 2011, she was recognized with the AutoVision Innovations Award and honored as a Monash University Distinguished Alumni Award recipient.


To learn more, you can check out the Agenda, and the Sponsors. Registration is open here.